Hydrochloric Acid → N-((2-aminothiazol-4-yl)methyl)-N,3-dimethylpyrazine-2-carboxamide
Reaktionsgleichung
[CH3:1][N:2]([CH2:12][C:13]1[N:14]=[C:15]([NH:18]C(=O)OC(C)(C)C)[S:16][CH:17]=1)[C:3]([C:5]1[C:6]([CH3:11])=[N:7][CH:8]=[CH:9][N:10]=1)=[O:4].Cl>O1CCOCC1>[NH2:18][C:15]1[S:16][CH:17]=[C:13]([CH2:12][N:2]([CH3:1])[C:3]([C:5]2[C:6]([CH3:11])=[N:7][CH:8]=[CH:9][N:10]=2)=[O:4])[N:14]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of tert-butyl 4-((N,2-dimethylpyrazine-3-carboxamido)methyl)thiazol-2-ylcarbamate (1.30 g, 3.6 mmol) in dioxane (10 mL) was treated with 4N HCl in dioxane (10 mL) for 2 hours. The resulting suspension was concentrated in vacuo to afford N-((2-aminothiazol-4-yl)methyl)-N,3-dimethylpyrazine-2-carboxamide (1.10 g).